- Home
- NWBI vs SUPN Comparison
NWBI vs SUPN Comparison
Compare NWBI & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWBI
- SUPN
- Stock Information
- Founded
- NWBI 1896
- SUPN 2005
- Country
- NWBI United States
- SUPN United States
- Employees
- NWBI N/A
- SUPN N/A
- Industry
- NWBI Major Banks
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- NWBI Finance
- SUPN Health Care
- Exchange
- NWBI Nasdaq
- SUPN Nasdaq
- Market Cap
- NWBI 1.6B
- SUPN 1.9B
- IPO Year
- NWBI N/A
- SUPN 2012
- Fundamental
- Price
- NWBI $12.80
- SUPN $31.55
- Analyst Decision
- NWBI Hold
- SUPN Hold
- Analyst Count
- NWBI 1
- SUPN 2
- Target Price
- NWBI $15.00
- SUPN $36.00
- AVG Volume (30 Days)
- NWBI 629.8K
- SUPN 682.9K
- Earning Date
- NWBI 07-22-2025
- SUPN 08-05-2025
- Dividend Yield
- NWBI 6.21%
- SUPN N/A
- EPS Growth
- NWBI N/A
- SUPN N/A
- EPS
- NWBI 0.90
- SUPN 1.11
- Revenue
- NWBI $518,578,999.00
- SUPN $667,997,000.00
- Revenue This Year
- NWBI $7.29
- SUPN N/A
- Revenue Next Year
- NWBI $11.29
- SUPN $12.02
- P/E Ratio
- NWBI $14.32
- SUPN $28.62
- Revenue Growth
- NWBI N/A
- SUPN 11.82
- 52 Week Low
- NWBI $10.75
- SUPN $25.55
- 52 Week High
- NWBI $15.42
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- NWBI 61.38
- SUPN 43.90
- Support Level
- NWBI $12.47
- SUPN $30.93
- Resistance Level
- NWBI $12.93
- SUPN $31.81
- Average True Range (ATR)
- NWBI 0.24
- SUPN 0.94
- MACD
- NWBI 0.05
- SUPN -0.13
- Stochastic Oscillator
- NWBI 80.00
- SUPN 25.44
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.